Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
Means for improving global food security by ensuring smallholder farmers have access to the latest innovations in crop genetics will be explored in a […]
World Food Prize panel to explore global food security through crop genetics Read More »
Patient advocates from across the country gathered in Washington, D.C., on October 23-24 for the BIO Patient and Health Advocacy Summit (PHAS). This event
PHAS 2024: Patient advocates unite to share stories and address barriers to treatment Read More »
“All of us have been paying attention and seeing the ‘AI high’ for the last several years,” said Ruchita Sinha, MBA, General Partner at
BIF 2024: AI experts discuss use cases, benefits, ROI Read More »
Biotech firms weighing an initial public offering (IPO) must consider timing, interest in their product, the macro environment—and whether they really need all the
BIO Investor Forum panel breaks down when, what, and why of IPOs Read More »
The Inflation Reduction Act (IRA) has been top of mind for many in the biotech industry. The first round of price negotiations and the
BIF 2024: ‘The IRA really disrupted how we think’ Read More »
The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in
BIO Investor Forum opens with encouraging news on financing Read More »
There is a great degree of renewed optimism for drug development in the neurodegenerative disease space. “Some of that optimism has obviously come from
BIF 2024: What’s happening with neurodegenerative disease targets and pipelines? Read More »
Bio.News is heading back to San Francisco for the Biotechnology Innovation Organization (BIO) Investor Forum, one of the only independent partnering events dedicated to
How to follow the 2024 BIO Investor Forum in San Francisco Read More »
Since 2019, the Biotechnology Innovation Organization (BIO) has worked with BBC StoryWorks Commercial Productions, the BBC’s award-winning branded content division, to bring stories of
BIO and BBC StoryWorks call for biotech stories Read More »
Neuroene Therapeutics is developing mitochondrial-protective small molecules for epilepsy, Parkinson’s, and mitochondrial diseases. The company’s CEO Sherine Chan, Ph.D., co-founded Neuroene with medicinal chemist
BIO Start-Up Stadium 2024: Meet Emerging Company winner Neuroene Therapeutics Read More »
